Overview

Seasonal Allergic Rhinitis In Pediatric Subjects

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the investigational drug is effective and safe in children with seasonal allergic rhinitis.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline